Innovate UK, Office for Life Sciences’ (OLS) · GB · UKRI

Advancing innovation in accelerated cancer diagnosis

Innovate UK, on behalf of the OLS Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices. Innovate UK

Deadline 2026-10-28

Official page ↗

Eligibility

Structured dimensions read from the official page. What do these mean? ↗

Host country

Organization type

University, Research Institute

Evidence: every dimension above is read from this scheme's official page — official page ↗.

Full eligibility text

See UKRI opportunity page for eligibility and institutional requirements.

Deadline

2026-10-28

Back to browse

Data sources & verification (for research-office review)

Where each item on this page was read from, so every claim can be verified against the original. Several values often come from the same official page — that page is named in the Source column. Anything we could not reach or parse is listed under Not captured / obstacles below.

Curated item	Value in this record	Source
Funding agency	Innovate UK, Office for Life Sciences’ (OLS)	www.ukri.org ↗
Country / funding source	GB · UKRI	same page as above — www.ukri.org ↗
Deadline	2026-10-28 — read from the official page	same page as above — www.ukri.org ↗
Funding amount	Not yet gathered	same page as above — www.ukri.org ↗
Eligibility	2 structured dimensions — see the eligibility panel above	same page as above — www.ukri.org ↗

Pages & application forms captured

Official opportunity page ↗

Not captured / obstacles

Official page text has not been archived for this record yet — treat field values as provisional.
No archived page text — the funding amount is “not yet gathered”, not necessarily unpublished.
No application-form file has been downloaded / analysed yet.

Data is collected from official funder pages only. Figures are machine-curated (rule + LLM where noted) and should be re-verified on the linked source before use.